Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NSF Grants Awarded to CUNY, University of Puget Sound, and More

Premium

Recent NSF Awards in Proteomics and Protein Research

Title: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
Principal Investigator: Michele Vittadello
Sponsor: CUNY Medgar Evers College
Start/End Date: Jan. 1, 2014 – June 30, 2014
Amount Awarded to Date: $50,000

Funds a customer discovery and business development effort to commercialize a new type of immobilized metal affinity chromatography resins based on graphene oxide nanosheets.


Title: Comparative Transcriptomic and Proteomic Analysis of Phytochrome Responses in Tomato
Principal Investigator: Andreas Madlung
Sponsor: University of Puget Sound
Start/End Date: Feb. 1, 2014 – Jan. 31, 2019
Amount Awarded to Date: $625,623

Funds study of transcriptomic and proteomic changes in tomato seedlings and phytochrome mutants during early development with the aim of better understanding light-mediated responses during seedling development.


Title: Delving Deeper into the Proteome
Principal Investigator: Frank Jahnke
Sponsor: Sonata Biosciences
Start/End Date: Jan. 1,2014 – June 30, 2014
Amount Awarded to Date: $150,000

Funds proof-of-concept work on a new methods for removing abundant proteins from human fluid samples including blood to improve proteomic analysis.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.